thisdrug what a medicine's name tells you

WHO naming stem · suffix · 17 listed names

-glitazar

dual peroxisome proliferator activated receptors-α and γ (PPAR- α,γ) agonists

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -glitazar as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -glitazar. So the letters glitazar sit at the end of the name (…glitazar).

All 17 names WHO lists under -glitazar

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. aleglitazar
  2. carfloglitazar
  3. cevoglitazar
  4. farglitazar
  5. imiglitazar
  6. indeglitazar
  7. muroglitazar
  8. naveglitazar
  9. oxeglitazar
  10. peliglitazar
  11. pemaglitazar
  12. ragaglitazar
  13. reglitazar
  14. saroglitazar
  15. sipoglitazar
  16. sodelglitazar
  17. tesaglitazar

Decode another name

Decoded

reglitazar

Listed INNCarries 2 WHO stems, most specific first: -glitazar …

  • -glitazarend of the nameWHO lists it hereWHO definition: dual peroxisome proliferator activated receptors-α and γ (PPAR- α,γ) agonists
  • gliinside the nameWHO lists it hereWHO definition: antihyperglycaemics

“reglitazar” is an INN that WHO lists under -glitazar, gli in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -glitazar (Part II B) and the 17 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.